Massachusetts General Hospital, United States
Adam S. Feldman, MD, MPH is the Chief of the Division of Urologic Oncology at Mass General Brigham and Associate Professor of Surgery at Harvard Medical School. He serves as the Program Director of The Combined Harvard Medical School Urologic Oncology Fellowship Program since 2015 and Associate Chair for Research for the Department of Urology at MGH since 2018. He completed his residency in Urology in 2006 and fellowship in Urologic Oncology in June 2008 at the Massachusetts General Hospital. His work during fellowship in novel proteomic biomarker discovery led to a Prostate Cancer Foundation Young Investigator Award and subsequently a Physician Research Training Award by the Department of Defense. He has since received several federally funded, foundation and industry sponsored research grants for his work in biomarker development, metabolomics and imaging in genitourinary malignancies. He has published over 100 peer-reviewed manuscripts, and has served on multiple regional, national and international grant review, scientific program and steering committees. In addition to his work in translational research, he has worked diligently to build multiple clinical outcomes databases at MGH in prostate cancer, urothelial cancer and renal cell carcinoma.
He focuses his clinical practice in the treatment of urothelial cancer, prostate cancer, kidney cancer and other genitourinary malignancies. He has been instrumental in the development of the MRI/ultrasound fusion prostate biopsy program and expanding alternative therapies for upper tract urothelial carcinoma at MGH, and worked together with his BWH counterpart to develop the first combined MGB clinical program, the Prostate Cancer Outreach Clinic, which strives to improve care to underserved communities. Through his nearly 20 years on staff at MGH, he has mentored numerous students, residents and fellows, and has been an invited speaker at several regional, national and international meetings. He is dedicated to excellence in clinical care, education and research.
Thursday, October 30, 2025
08:00 - 09:00 GMT+0
MC-02: De-Intensifying Treatment Strategies for Low and Intermediate Risk Disease
Thursday, October 30, 2025
14:10 - 14:20 GMT+0
Friday, October 31, 2025
08:00 - 09:00 GMT+0
Saturday, November 1, 2025
14:24 - 14:39 GMT+0